The AI giant is expected to list on the NASDAQ as early as next month, while OpenAI delays its plans to go public.

Anthropic will go public before OpenAI, according to betting platform Kalshi—ninety-three percent of those making predictions say so. Because the figure doesn’t have to add to 100, 11% predict OpenAI will go first.

Goldman Sachs Asset Management, Franklin Templeton, and Fidelity International Ltd. are among the global first set to participate as anchor investors in National Stock Exchange of India Ltd.’s initial public offering, according to people familiar with the matter, as the bourse prepares to raise as much as Rs 22,600 crore ($2.4 billion).

SpaceX had a gigantic IPO, and more shares are coming as insiders' lockups expire, potentially clouding the picture for other large IPOs.

OpenAI CEO Sam Altman just admitted that the company’s long-awaited, potentially record-setting IPO won’t be happening this year. Instead of rumored financial woes, Altman is blaming AI safety concerns for the timeline shift.

The Claude maker has selected Nasdaq for a potential listing and could seek to raise as much as $100 billion, while its annualized revenue has surged above $65 billion and adjusted operating income is expected to remain positive for a second consecutive quarter.

They were triggered by warnings from researchers at Anthropic that there were credible fears within the company that AI could wipe out humanity in a matter of years. It is unusual, to say the least, for people within a firm to publicly air such doomsday warnings about their most cutting-edge products.

Flotation of Dangote Petroleum Refinery has a low entry price but many ordinary people are unaware or have more pressing needs

CEO Sam Altman said he did not think OpenAI would go public this year as widely expected, and separately called for increased safety evaluations. OpenAI CEO Sam Altman said he didn’t think the company’s highly anticipated IPO would happen this year, in an interview released Saturday.

Electra Therapeutics is hoping to raise up to $341.9 million in a surge of IPO funding to power the clinical development of its inflammatory disorder drug ipsoprubart. | Electra Therapeutics is hoping to raise up to $341.

Sept 14 (Reuters) - CVC-backed Bamboo Insurance Services is targeting a valuation of up to $3.13 billion in its U.S. initial public offering, the company revealed in a filing on Monday. The Midvale, Utah-based company's selling shareholders are seeking up to $700 million by offering 35 million shares priced between $18 and $20 apiece.

The allotment of shares in Manipal Payment & Identity Solutions' Rs 805-crore initial public offering (IPO) is expected to be finalised today, September 15, after the issue saw a modest subscription during its three-day bidding window.